"Le Centre Cardiologique d'Evecquemont est un établissement de santé pluridisciplinaire situé à Evecquemont, en Ile-de-France. Il fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée."

During the past decade, Centre Cardiologique d'Evecquemont conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Cardiologique d'Evecquemont" #1 sponsor was "MINVASYS" with 3 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Biotronik AG" with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "MicroPort CRM" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Cardiologique d'Evecquemont" #1 collaborator was "European Cardiovascular Research Center" with 2 trials as a collaborator and "Biotronik France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centre Cardiologique d'Evecquemont" are "Coronary Artery Disease" (3 trials), "Coronary Disease" (2 trials), "Atrial Arrhythmia" (1 trials), "In-stent Coronary Artery Restenosis" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Centre Cardiologique d'Evecquemont" in a lesser frequency.

Most popular intervention types in "Centre Cardiologique d'Evecquemont" are "Device" (5 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Danubio paclitaxel-eluting balloon" (2 trials), "Eplerenone" (1 trials), "Nile PAX® paclitaxel-eluting coronary stent" (1 trials), "Orsiro Mission DES" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Cardiologique d'Evecquemont" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Centre Cardiologique d'Evecquemont". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre Cardiologique d'Evecquemont, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Cardiologique d'Evecquemont, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".